Fate Therapeutics Inc
FATE
Market Cap$150.13M
Close$
$8.54
721.3% upside
Current Fair Value
721.3% upsideUndervalued by 721.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $150.13 Million |
|---|---|
| Enterprise Value | $199.73 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.64 |
| Beta | 2.42 |
| Outstanding Shares | 115,727,169 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.81 |
|---|---|
| PEG | -14.66 |
| Price to Sales | - |
| Price to Book Ratio | 0.52 |
| Enterprise Value to Revenue | 14.85 |
| Enterprise Value to EBIT | -1.02 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Fate Therapeutics Inc
CEO: William Rastetter